Targeting tumor–stromal interactions in triple-negative breast cancer using a human vascularized micro-tumor model
Open accessPublished version of a preprint
The DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.
Abstract
Triple-negative breast cancer (TNBC) is highly aggressive with limited available treatments. Stromal cells in the tumor microenvironment (TME) are crucial in TNBC progression; however, understanding the molecular basis of stromal cell activation and tumor-stromal crosstalk in TNBC is limited. To investigate therapeutic targets in the TNBC stromal niche, we used an advanced human in vitro microphysiological system called the vascularized micro-tumor (VMT). Using single-cell RNA sequencing, we revealed that normal breast tissue stromal cells activate neoplastic signaling pathways in the TNBC TME. By comparing interactions in VMTs with clinical data, we identified therapeutic targets at the tumor-stromal interface with potential clinical significance. Combining treatments targeting Tie2 signaling with paclitaxel resulted in vessel normalization and increased efficacy of paclitaxel in the TNBC VMT. Dual inhibition of HER3 and Akt also showed efficacy against TNBC. These data demonstrate the potential of inducing a favorable TME as a targeted therapeutic approach in TNBC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The model has been adapted to multiple cancer types, including immunologically ‘cold’ or ‘mixed’ tumors such as breast cancer, MSS subtype colorectal cancer and ovarian cancer, which display varying degrees of vascular disruption (Jahid et al., 2022; Hachey et al., 2024), Hachey et al. (2021)).”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Hachey et al., 2024
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
Yu, G., Wang, L.-G., Han, Y., & He, Q.-Y. (2012) · OMICS: A Journal of Integrative Biology · doi:10.1089/omi.2011.0118 · Cited by 36,259 · cited 2×
“Pathway analysis was performed using clusterProfiler [35] with the GO Biological Process 2021 database on the top 100 differentially expressed genes.”
MethodSiegel, R. L., Miller, K. D., Wagle, N. S., & Jemal, A. (2023) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21763 · Cited by 16,303 · cited 1×
“Consequently, TNBC disproportionally accounts for 30% of all breast cancer-related mortality, with approximately 150,000 deaths estimated in 2023 [2].”
BackgroundComprehensive Integration of Single-Cell Data
Stuart, T., Butler, A., Hoffman, P., Hafemeister, C., Papalexi, E., Mauck, W. M., Hao, Y., Stoeckius, M., Smibert, P., & Satija, R. (2019) · Cell · doi:10.1016/j.cell.2019.05.031 · Cited by 15,453
Integrating single-cell transcriptomic data across different conditions, technologies, and species
Butler, A., Hoffman, P., Smibert, P., Papalexi, E., & Satija, R. (2018) · Nature Biotechnology · doi:10.1038/nbt.4096 · Cited by 13,174
Inference and analysis of cell-cell communication using CellChat
Jin, S., Guerrero-Juarez, C. F., Zhang, L., Chang, I., Ramos, R., Kuan, C.-H., Myung, P., Plikus, M. V., & Nie, Q. (2021) · Nature Communications · doi:10.1038/s41467-021-21246-9 · Cited by 8,409 · cited 1×
“LIANA aggregates results from multiple cell–cell communication pipelines, and the results from the CellChat [76], Connectome [77], iTALK [78], NATMI [79], and SingleCellSignalR [80] pipelines were computed.”
MethodTrapnell, C., Cacchiarelli, D., Grimsby, J., Pokharel, P., Li, S., Morse, M., Lennon, N. J., Livak, K. J., Mikkelsen, T. S., & Rinn, J. L. (2014) · Nature Biotechnology · doi:10.1038/nbt.2859 · Cited by 7,314 · cited 1×
“Pseudotime was performed using Monocle v2 [31, 82].”
Spatial reconstruction of single-cell gene expression data
Satija, R., Farrell, J. A., Gennert, D., Schier, A. F., & Regev, A. (2015) · Nature Biotechnology · doi:10.1038/nbt.3192 · Cited by 7,055 · cited 1×
“Count matrices were loaded into RStudio (1.2.5042 version, R version 4.0.4 [61, 62]) and converted into a Seurat object using the Seurat R Package (version 4.0.0.9015) [63, 64].”
MethodInfluentialReversed graph embedding resolves complex single-cell trajectories
Qiu, X., Mao, Q., Tang, Y., Wang, L., Chawla, R., Pliner, H. A., & Trapnell, C. (2017) · Nature Methods · doi:10.1038/nmeth.4402 · Cited by 5,070 · cited 2×
“Pseudotime was performed using Monocle v2 [31, 82].”
MethodAran, D., Looney, A. P., Liu, L., Wu, E., Fong, V., Hsu, A., Chak, S., Naikawadi, R. P., Wolters, P. J., Abate, A. R., et al. (2019) · Nature Immunology · doi:10.1038/s41590-018-0276-y · Cited by 4,984 · cited 1×
“…of known markers (ECs: PECAM1, CDH5, VWF, KDR, CLDN5 [67], Fibroblasts: PDGFRA, PDG-FRB, COL1A1 [68], Stroma: PDGFRB, TPM1, ACTA2 [68], Cycling cells: MKI67 and TOP2A [69], and Tumor: KRT18 and EPCAM [70]), and cell types were later confirmed using the SingleR R package (version 1.4.1) [71].”
InfluentialMcGinnis, C. S., Murrow, L. M., & Gartner, Z. J. (2019) · Cell Systems · doi:10.1016/j.cels.2019.03.003 · Cited by 4,521
Cited by
Tissue‐Engineered Microvessels: A Review of Current Engineering Strategies and Applications
Zhao, N., Pessell, A. F., Zhu, N., & Searson, P. C. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202303419 · Cited by 43
Palma, M. (2025) · Vaccines · doi:10.3390/vaccines13040344 · Cited by 41
Martier, A. T., Chen, Z., Schaps, H., Mondrinos, M. J., & Fang, J. (2024) · Frontiers in Physiology · doi:10.3389/fphys.2024.1425618 · Cited by 25
Evolving immunotherapeutic solutions for triple-negative breast carcinoma
Wu, S., Ge, A., Deng, X., Liu, L., & Wang, Y. (2024) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2024.102817 · Cited by 24
Gaebler, D., Hachey, S. J., & Hughes, C. C. W. (2024) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2024.1462293 · Cited by 22
“Additionally, it was revealed that stromal cells from normal breast tissue activate oncogenic signaling pathways within the TNBC microenvironment.”
BackgroundMethodInfluentialSelf-citation
Metadata
- Authors
- Hachey, S. J., Hatch, C. J., Gaebler, D., Mocherla, A., Nee, K., Kessenbrock, K., & Hughes, C. C. W.
- Affiliations
- University of California, Irvine (US)
- Corresponding author
- Hachey, Stephanie J.
- Venue
- Breast Cancer Research
- Published
- 2024-01-05
- Volume
- 26
- Issue
- 1
- Pages
- 5-5
- ISSN
- 1465-5411 (ISSN-L)
- 1465-542X
- PMC
- PMC10768273
- OpenAlex
- W4390616031
- Cited by
- 24
- References
- 81
- Citations by year
- 2026: 8 · 2025: 8 · 2024: 8
- FWCI
- 4.11
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Breast Cancer Research (publishedVersion, cc-by)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Center for Advancing Translational Sciences (TR001415)
- National Heart, Lung, and Blood Institute (T32HL116270)
- National Cancer Institute, United States (U54CA217378)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Keywords
- triple-negative breast cancer, tumor-stroma interactions, tumor microenvironment, Tie2 signaling, paclitaxel, HER3, AKT inhibition, vessel normalization, therapeutic target, single-cell RNA sequencing
- MeSH terms
- Breast, Humans, Signal Transduction, Stromal Cells, Paclitaxel, Tumor Microenvironment, Triple Negative Breast Neoplasms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Targeting tumor–stromal interactions in triple-negative breast cancer using a human vascularized micro-tumor model. https://app.cochat.ai/papers/10.1186/s13058-023-01760-y
- The paper
- Hachey, S. J., Hatch, C. J., Gaebler, D., Mocherla, A., Nee, K., Kessenbrock, K., & Hughes, C. C. W. (2024). Targeting tumor–stromal interactions in triple-negative breast cancer using a human vascularized micro-tumor model. Breast Cancer Research. https://doi.org/10.1186/s13058-023-01760-y
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.